Literature DB >> 19942591

Circulating microparticles and procoagulant activity in elderly patients.

Anne Forest1, Eric Pautas, Patrick Ray, Dominique Bonnet, Marc Verny, Nicolas Amabile, Chantal Boulanger, Bruno Riou, Alain Tedgui, Ziad Mallat, Jacques Boddaert.   

Abstract

BACKGROUND: Microparticles (MP) are shed membrane vesicles released from activation or apoptosis of several cell types and carry a procoagulant activity. Age is associated with a procoagulant state, but the role of MP in this setting is unknown, as the relationship of MP to aging in humans. We tested the hypotheses that elderly persons compared with young persons may have different patterns of expression of MP and procoagulant activity in stable or septic conditions.
METHODS: Patients from Emergency and Geriatric Departments were divided into four groups according to their age (< 50 or > or = 75 years old) and the presence of systemic infection (yes or no). The diagnosis of infection was reached when it was classified as certain or possible by an expert panel. Circulating MP were isolated from venous citrated blood. Cytofluorometry using specific antibodies was performed to determine the origins of MP (endothelial microparticles [EMP], red blood cell microparticles, or platelet microparticles). Procoagulant activity was determined using annexin V (prothrombinase activity) and tissue factor (TF) assays.
RESULTS: One hundred and eleven patients were included. Elderly patients expressed a decrease in EMP in stable conditions, associated with a decrease in procoagulant annexin V MP in septic conditions (p < .05), and higher EMP levels were found in elderly infected patients who died during hospital stay than in survivors (p = .04). Compared with young patients, response to sepsis was altered in elders concerning EMP, annexin V MP, and TF-bearing MP.
CONCLUSION: Elderly patients expressed a different pattern of MP in stable conditions, with a different response to sepsis in procoagulant activity modification.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19942591     DOI: 10.1093/gerona/glp187

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  16 in total

Review 1.  Influence of red blood cell-derived microparticles upon vasoregulation.

Authors:  Ahmed S Said; Allan Doctor
Journal:  Blood Transfus       Date:  2017-05-15       Impact factor: 3.443

2.  Endothelial microparticles induce inflammation in acute lung injury.

Authors:  Keely L Buesing; John C Densmore; Sushma Kaul; Kirkwood A Pritchard; Jason A Jarzembowski; David M Gourlay; Keith T Oldham
Journal:  J Surg Res       Date:  2010-06-09       Impact factor: 2.192

Review 3.  Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases.

Authors:  Melissa Cunningham; Natalia Marks; April Barnado; Jena R Wirth; Gary Gilkeson; Margaret Markiewicz
Journal:  Semin Thromb Hemost       Date:  2014-08-31       Impact factor: 4.180

4.  Sepsis-Associated Coagulopathy.

Authors:  Ecaterina Scarlatescu; Dana Tomescu; Sorin Stefan Arama
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-11-08

Review 5.  Milk fat globule epidermal growth factor VIII signaling in arterial wall remodeling.

Authors:  Mingyi Wang; Hejia H Wang; Edward G Lakatta
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

6.  Preliminary study of microparticle coagulation properties in septic patients with disseminated intravascular coagulation.

Authors:  Shishuai Meng; Kai Kang; Dongsheng Fei; Songlin Yang; Quankuan Gu; ShangHa Pan; Mingyan Zhao
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

7.  Microparticles induce cell cycle arrest through redox-sensitive processes in endothelial cells: implications in vascular senescence.

Authors:  Dylan Burger; Dylan G Kwart; Augusto C Montezano; Naomi C Read; Christopher R J Kennedy; Charlie S Thompson; Rhian M Touyz
Journal:  J Am Heart Assoc       Date:  2012-06-22       Impact factor: 5.501

8.  Clinical CVVH model removes endothelium-derived microparticles from circulation.

Authors:  Abdelhafeez H Abdelhafeez; Paul M Jeziorczak; Terry R Schaid; Susan L Hoefs; Sushma Kaul; Rahul Nanchal; Elizabeth R Jacobs; John C Densmore
Journal:  J Extracell Vesicles       Date:  2014-02-27

Review 9.  Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases.

Authors:  Margaret Markiewicz; Erin Richard; Natalia Marks; Anna Ludwicka-Bradley
Journal:  J Aging Res       Date:  2013-10-28

Review 10.  Extracellular Vesicles as New Players in Cellular Senescence.

Authors:  Lorena Urbanelli; Sandra Buratta; Krizia Sagini; Brunella Tancini; Carla Emiliani
Journal:  Int J Mol Sci       Date:  2016-08-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.